Loan Agreements in the Pharmaceuticals Industry

718 Contracts & Agreements

Browse by Company

4Front Ventures Corp. (1 contract)
Acacia Diversified Holdings, Inc. (2)
ACELRX PHARMACEUTICALS INC (9)
Acer Therapeutics Inc. (2)
ACHILLION PHARMACEUTICALS INC (1)
Aclaris Therapeutics, Inc. (2)
Acreage Holdings, Inc. (6)
ACURA PHARMACEUTICALS, INC (11)
Adamis Pharmaceuticals Corp (13)
Aegerion Pharmaceuticals, Inc. (12)
AERIE PHARMACEUTICALS INC (2)
AGILE THERAPEUTICS INC (4)
AKESIS PHARMACEUTICALS, INC. (1)
Akorn (8)
Alexza Pharmaceuticals Inc. (1)
ALIMERA SCIENCES INC (20)
Allergan, plc (1)
Altus Pharmaceuticals Inc. (1)
AmeriCann, Inc. (15)
Amneal Pharmaceuticals, Inc. (4)
Amphastar Pharma (10)
Ampio Pharmaceuticals, Inc. (1)
AMYLIN PHARMACEUTICALS INC (1)
Anacor Pharmaceuticals, Inc. (3)
ANI Pharma Inc (2)
Anthera Pharmaceuticals Inc (2)
APRICUS BIOSCIENCES, INC. (2)
ARIAD PHARMACEUTICALS INC (1)
Arog Pharmaceuticals, Inc. (3)
Assertio Holdings, Inc. (1)
Assertio Therapeutics, Inc (1)
ATAI Life Sciences B.V. (2)
Auspex Pharmaceuticals, Inc. (4)
AUXILIUM PHARMACEUTICALS INC (4)
Axsome Therapeutics, Inc. (8)
AYTU BIOSCIENCE, INC (4)
BENTLEY PHARMACEUTICALS INC (1)
BIODELIVERY SCIENCES INTERNATIONAL INC (7)
Biofrontera Inc. (2)
BioPharmX Corp (2)
Biostar Pharmaceuticals, Inc. (1)
BODY & MIND INC. (12)
Bristol-Myers Squibb (2)
CADENCE PHARMACEUTICALS INC (4)
Canbiola, Inc. (1)
Cannabics Pharmaceuticals Inc. (1)
Cantabio Pharmaceuticals Inc. (7)
Celator Pharmaceuticals Inc (2)
Cerecor Inc. (10)
CHINA PHARMA HOLDINGS, INC. (2)
China Pharmaceuticals Inc (2)
Clearside Biomedical, Inc. (9)
CLS Holdings USA, Inc. (4)
COLLAGENEX PHARMACEUTICALS INC (1)
COLLEGIUM PHARMACEUTICAL, INC (13)
ContraVir Pharmaceuticals, Inc. (1)
COSMO VENTURES INC (1)
CUBIST PHARMACEUTICALS INC (1)
CUMBERLAND PHARMACEUTICALS INC (22)
Cure Pharmaceutical Holding Corp. (1)
CymaBay Therapeutics, Inc. (1)
DiCE MOLECULES HOLDINGS, LLC (2)
Dova Pharmaceuticals Inc. (2)
DURECT CORP (8)
Egalet Corp (4)
Elanco Animal Health Inc (8)
ELITE PHARMACEUTICALS INC (6)
Elixir Pharmaceuticals, Inc. (2)
Eloxx Pharmaceuticals, Inc. (3)
Endo International plc (1)
EPIX Pharmaceuticals, Inc. (1)
Evofem Biosciences, Inc. (1)
Evoke Pharma Inc (6)
Evolus, Inc. (6)
Exactus, Inc. (2)
EYENOVIA, INC. (5)
EyePoint Pharmaceuticals, Inc. (6)
Fresenius Kabi Pharmaceuticals Holding, Inc. (3)
Furiex Pharmaceuticals, Inc. (1)
GB SCIENCES INC (2)
GENAISSANCE PHARMACEUTICALS INC (1)
GREEN HYGIENICS HOLDINGS INC. (2)
HARROW HEALTH, INC. (10)
Horizon Pharma plc (8)
IMAGING3 INC (2)
Innovive Pharmaceuticals, Inc. (1)
INSPIRE PHARMACEUTICALS INC (2)
IntelGenx Technologies Corp. (3)
Intersect ENT, Inc. (1)
ISTA PHARMACEUTICALS INC (12)
Item 9 Labs Corp. (3)
Iterum Therapeutics plc (4)
Jaguar Health, Inc. (3)
JAVELIN PHARMACEUTICALS, INC (3)
Journey Medical Corp (5)
JUNIPER PHARMACEUTICALS INC (1)
Jushi Holdings Inc. (3)
Kala Pharmaceuticals, Inc. (7)
Kaleido Biosciences, Inc. (2)
KEMPHARM, INC (3)
KID CASTLE EDUCATIONAL CORP (6)
KOS PHARMACEUTICALS INC (1)
Lannett Company, Inc. (2)
Level Brands, Inc. (1)
Lexaria Bioscience Corp. (2)
Lipocine Inc. (2)
Liquidia Corp (3)
Liquidia Technologies Inc (2)
Lowell Farms Inc. (1)
Luckwel Pharmaceuticals Inc. (1)
Mallinckrodt (2)
MAP Pharmaceuticals, Inc. (5)
MARINUS PHARMACEUTICALS INC (5)
Medicine Man Technologies, Inc. (2)
Melt Pharmaceuticals, Inc. (3)
MEMORY PHARMACEUTICALS CORP (3)
MiddleBrook Pharmaceuticals, Inc. (1)
MIRA PHARMACEUTICALS, INC. (1)
MJ Holdings, Inc. (2)
Mylan N.V. (1)
MYnd Analytics, Inc. (4)
Nabriva Therapeutics plc (5)
NEKTAR THERAPEUTICS (1)
Neos Therapeutics, Inc. (3)
Notis Global, Inc. (1)
Novan, Inc. (3)
OMEROS CORP (20)
Omthera Pharmaceuticals, Inc. (1)
ORAMED PHARMACEUTICALS INC. (1)
OTONOMY, INC. (3)
Pacira Pharmaceuticals, Inc. (3)
PANACOS PHARMACEUTICALS, INC. (2)
Paratek Pharmaceuticals, Inc. (10)
Perrigo (4)
PetLife Pharmaceuticals, Inc. (2)
Petros Pharmaceuticals, Inc. (4)
Phathom Pharmaceuticals, Inc. (8)
Phibro Animal Health Corporation (7)
PLAYERS NETWORK (1)
PLx Pharma Inc. (1)
PONIARD PHARMACEUTICALS, INC. (1)
PRAECIS PHARMACEUTICALS INC (1)
Prestige Brands Holdings Inc (2)
Processa Pharmaceuticals, Inc. (2)
Provention Bio, Inc. (2)
Pulmatrix, Inc. (2)
QUATRX PHARMACEUTICALS CO (2)
RADIENT PHARMACEUTICALS Corp (1)
Rani Therapeutics Holdings, Inc. (4)
REATA PHARMACEUTICALS INC (4)
Reliant Pharmaceuticals, Inc. (1)
resTORbio, Inc. (8)
Revance Therapeutics, Inc. (4)
Rib-X Pharmaceuticals, Inc. (1)
ROCK CREEK PHARMACEUTICALS, INC. (3)
Sagent Pharmaceuticals, Inc. (5)
SALIX PHARMACEUTICALS LTD (1)
Satsuma Pharmaceuticals, Inc. (1)
SCICLONE PHARMACEUTICALS INC (3)
scPharmaceuticals Inc. (4)
SCYNEXIS INC (4)
Sienna Biopharmaceuticals, Inc. (2)
SIGA TECHNOLOGIES INC (4)
Sonoma Pharmaceuticals, Inc. (2)
Strongbridge Biopharma plc (2)
Sucampo Pharmaceuticals, Inc. (1)
SUNWIN STEVIA INTERNATIONAL, INC. (3)
Supernus Pharmaceuticals, Inc. (5)
SYNERGY PHARMACEUTICALS, INC. (3)
Target Group Inc. (1)
Tarsus Pharmaceuticals, Inc. (1)
TAURIGA SCIENCES, INC. (1)
Terra Tech Corp. (7)
TETRAPHASE PHARMACEUTICALS INC (4)
TEVA PHARMACEUTICAL INDUSTRIES LTD (6)
Textmunication Holdings, Inc. (2)
Tilray, Inc. (1)
TILT Holdings Inc. (1)
TITAN PHARMACEUTICALS INC (8)
Tongli Pharmaceuticals (USA), Inc. (4)
Trevi Therapeutics, Inc. (2)
Tribute Pharmaceuticals Canada Inc. (2)
Tricida, Inc. (8)
Trubion Pharmaceuticals, Inc (1)
Upjohn Inc (2)
Urovant Sciences Ltd. (3)
Verona Pharma plc (4)
Verrica Pharmaceuticals Inc. (6)
VIA Pharmaceuticals, Inc. (4)
Vitae Pharmaceuticals, Inc (2)
VIVUS INC (1)
Vyrix Pharmaceuticals, Inc. (2)
XERIS PHARMACEUTICALS INC (9)
Zoetis (1)
ZOGENIX, INC. (5)
Zomedica Pharmaceuticals Corp. (2)

Recent Contracts

First Amendment to Loan Agreement, dated as of September 13, 2023, between Avalo Therapeutics, Inc. and Horizon Credit II LLC, Horizon Funding Trust 2019-1, Horizon Funding I,... (Cerecor Inc., Filed With SEC on September 13, 2023)
Loan Termination Agreement dated September 1, 2023, by and between CGSF Group LLC and SFNY Holdings, Inc (TILT Holdings Inc., Filed With SEC on September 7, 2023)
Revolving Credit Loan Agreement, dated as of September 5, 2023, by and between Cumberland Pharmaceuticals Inc. and Pinnacle Bank (CUMBERLAND PHARMACEUTICALS INC, Filed With SEC on September 6, 2023)
First Amendment to Amended and Restated Loan and Security Agreement dated July 31, 2023 (4Front Ventures Corp., Filed With SEC on September 1, 2023)
Bridge Loan Agreement dated as of August 30, 2023 by and between Zevra Therapeutics, Inc. and Acer Therapeutics Inc (KEMPHARM, INC, Filed With SEC on August 31, 2023)
Loan Purchase Agreement dated as of August 30, 2023 by and among Zevra Therapeutics, Inc., and Nantahala Capital Management, LLC and the other sellers party thereto (KEMPHARM, INC, Filed With SEC on August 31, 2023)
Secured Bridge Loan Agreement, dated August 30, 2023, by and among Timber Pharmaceuticals, Inc., Timber Pharmaceuticals, LLC, BioPharmX, Inc. and LEO US Holding, Inc (BioPharmX Corp, Filed With SEC on August 31, 2023)
First Amendment to the Amended and Restated Loan Agreement between IntelGenx Technologies Corp. and ATAI Life Sciences AG, dated August 31, 2023 (IntelGenx Technologies Corp., Filed With SEC on August 31, 2023)
Bridge Loan Agreement dated as of August 30, 2023 by and between Zevra Therapeutics, Inc. and Acer Therapeutics Inc (Acer Therapeutics Inc., Filed With SEC on August 31, 2023)
Omnibus Amendment No. 1 to Fee Letter and Amendment No. 2 to Superpriority Debtor-in-Possession Loan and Security Agreement, dated August 21, 2023, by and between Novan, Inc., EPI... (Novan, Inc., Filed With SEC on August 24, 2023)
Amendment to Forbearance Agreement, dated as of August 15, 2023, among Mallinckrodt plc, Mallinckrodt International Finance S.A., Mallinckrodt CB LLC, certain lenders party... (Mallinckrodt, Filed With SEC on August 15, 2023)
Sixth Amendment to Loan and Security Agreement dated as of May 17, 2023, by and among Alimera Sciences, Inc., SLR Investment Corp., as Collateral Agent, and the parties signatory... (ALIMERA SCIENCES INC, Filed With SEC on August 11, 2023)
Fifth Amendment to Loan and Security Agreement, dated as of May 16, 2023, by and among East West Bank, Journey Medical Corporation and JG Pharma, Inc (Journey Medical Corp, Filed With SEC on August 10, 2023)
Senior Secured, Super-Priority Debtor-in-Possession Loan and Security Agreement dated as of August 9, 2023, among Sorrento Therapeutics, Inc., Scintilla Pharmaceuticals, Inc., the... (ORAMED PHARMACEUTICALS INC., Filed With SEC on August 9, 2023)
Amendment No. 1 to Term Loan Credit Agreement, dated as of May 30, 2023, entered into by and among Amneal Pharmaceuticals LLC, the Guarantors, and JPMorgan Chase Bank, N.A. as... (Amneal Pharmaceuticals, Inc., Filed With SEC on August 8, 2023)
Amendment No.1 to Revolving Credit and Term Loan Agreement, dated as of April 20, 2023, by and among Rondo Holdings, LLC, Rondo Intermediate Holdings, LLC, the Subsidiary Loan... (Amneal Pharmaceuticals, Inc., Filed With SEC on August 8, 2023)
Fourth Amendment to Loan and Security Agreement, dated May 8, 2023, by and among Axsome Therapeutics, Inc., the Lenders who from time to time may be party thereto, and Hercules... (Axsome Therapeutics, Inc., Filed With SEC on August 7, 2023)
Receivables Loan Agreement among Elanco SPEAR LLC, Elanco US Inc., The Various Lenders and Lender Agents from Time to Time Party Thereto and Coperatieve Rabobank U.A., New York... (Elanco Animal Health Inc, Filed With SEC on August 7, 2023)
Fourth Amendment to Loan and Security Agreement, dated August 1, 2023, by and among the Registrant, Combangio, Inc. and Oxford Finance LLC, as collateral agent and lender (Kala Pharmaceuticals, Inc., Filed With SEC on August 4, 2023)
Fifth Amendment to Loan and Security Agreement, dated August 2, 2023, by and among the Registrant, Combangio, Inc. and Oxford Finance LLC, as collateral agent and lender (Kala Pharmaceuticals, Inc., Filed With SEC on August 4, 2023)
Third Amendment to Loan Agreement, dated as of June 23, 2023, by and among Collegium Pharmaceutical, Inc., the guarantors party thereto, BioPharma Credit PLC, and Bio Pharma... (COLLEGIUM PHARMACEUTICAL, INC, Filed With SEC on August 3, 2023)
Third Amendment to Loan Agreement, dated as of May 9, 2023, by and among Evolus, Inc. (as Borrower and a Credit Party), BioPharma Credit PLC (as Collateral Agent), BPCR Limited... (Evolus, Inc., Filed With SEC on August 2, 2023)
Loan Modification Agreement (AmeriCann, Inc., Filed With SEC on August 1, 2023)
Loan and Security Agreement, dated July 14, 2023, by and among Novan, Inc., EPI Health, LLC and Ligand Pharmaceuticals, Incorporated (Novan, Inc., Filed With SEC on July 17, 2023)
Superpriority Debtor-in-Possession Loan and Security Agreement, dated July 17, 2023, by and between Novan, Inc., EPI Health, LLC and Ligand Pharmaceuticals, Incorporated (Novan, Inc., Filed With SEC on July 17, 2023)
Forbearance Agreement, dated as of July 16, 2023, among Mallinckrodt plc, Mallinckrodt International Finance S.A., Mallinckrodt CB LLC, certain lenders party thereto and Acquiom... (Mallinckrodt, Filed With SEC on July 17, 2023)
Amended Loan Schedule to the Amended, Consolidated and Restated Secured Promissory Note dated November 10, 2022 issued to Abuse Deterrent Pharma, LLC on May 19, 2023 aggregating... (ACURA PHARMACEUTICALS, INC, Filed With SEC on June 30, 2023)
Promissory Note and Loan Agreement, dated April 28, 2023, between MIRA Pharmaceuticals, Inc. and Bay Shore Trust (MIRA PHARMACEUTICALS, INC., Filed With SEC on June 29, 2023)
Company Loan and Security Agreement, dated June 20, 2023 (Textmunication Holdings, Inc., Filed With SEC on June 23, 2023)
Sixth Amendment to Loan and Security Agreement, dated May 30, 2023 (resTORbio, Inc., Filed With SEC on June 5, 2023)
Second Amendment to the Loan and Security Agreement between the Registrant, ATAI Life Sciences AG, certain of the Registrants subsidiaries from time to time party thereto as a... (ATAI Life Sciences B.V., Filed With SEC on May 31, 2023)
Loan Agreement dated May 11, 2023 (MJ Holdings, Inc., Filed With SEC on May 23, 2023)
Fifth Amendment to Loan and Security Agreement dated as of March 24, 2023, by and among Alimera Sciences, Inc., SLR Investment Corp, as Collateral Agent, and the parties signatory... (ALIMERA SCIENCES INC, Filed With SEC on May 15, 2023)
Loan and Security Agreement, dated as of May 8, 2023, between the Company, as Borrower, and MidCap Business Credit LLC, as Lender (Biofrontera Inc., Filed With SEC on May 12, 2023)
First Amendment, dated March 7, 2023, to the Loan and Security Agreement, dated as of September 30, 2021, by and among Hercules Capital, Inc., the Company, Zikani Therapeutics,... (Eloxx Pharmaceuticals, Inc., Filed With SEC on May 12, 2023)
Second Amendment to Loan Documents by and among Avenue Capital Management II L.P., certain lenders and Aytu BioPharma, Inc., dated March 24, 2023 (AYTU BIOSCIENCE, INC, Filed With SEC on May 11, 2023)
Amendment No. 4 to Loan and Security Agreement by and among Neos Therapeutics, Inc., Neos Therapeutics Brands, LLC, Neos Therapeutics, LP, Neos Therapeutics Commercial, LLC,... (AYTU BIOSCIENCE, INC, Filed With SEC on May 11, 2023)
Loan and Security Agreement dated December 14, 2022, between the Company and B. Riley Commercial Capital, LLC (HARROW HEALTH, INC., Filed With SEC on May 11, 2023)
Loan Agreement, dated April 6, 2023, by and between FVCbank, Dalitso LLC, JREHVA, LLC, Jushi VA, LLC and Jushi Holdings Inc (Jushi Holdings Inc., Filed With SEC on April 12, 2023)
Supplement to the Loan and Security Agreement, dated November 22, 2022, by among Eyenovia, Inc., Avenue Capital Management II, L.P., Avenue Venture Opportunities Fund, L.P. and... (EYENOVIA, INC., Filed With SEC on March 31, 2023)